Tidemark’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311 Hold
23
﹤0.01% 866
2026
Q1
$138 Hold
23
﹤0.01% 889
2025
Q4
$165 Hold
23
﹤0.01% 641
2025
Q3
$246 Hold
23
﹤0.01% 666
2025
Q2
$223 Sell
23
-8
-26% -$83 ﹤0.01% 687
2025
Q1
$462 Buy
+31
New +$477 ﹤0.01% 674
2024
Q4
Sell
-31
Closed -$592 667
2024
Q3
$592 Hold
31
﹤0.01% 590
2024
Q2
$642 Sell
31
-7
-18% -$139 ﹤0.01% 579
2024
Q1
$715 Buy
38
+11
+41% +$189 ﹤0.01% 653
2023
Q4
$389 Buy
+27
New +$367 ﹤0.01% 665

Other funds holding OGN

Tidemark's OGN Position: Q2 2026 in Review

Tidemark held its Organon & Co (OGN) position steady in Q2 2026 at 23 shares worth $311. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Tidemark first reported a position in OGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $715 in Q1 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Tidemark held 23 shares of Organon & Co worth $311 as of Q2 2026.
  • Tidemark left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #866 holding.
  • Tidemark first reported a position in Organon & Co in Q4 2023 and has held it in 10 quarters since.
  • Tidemark's Organon & Co position peaked at $715 in Q1 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.